15 November - 16 November 2021

3rd SCI-RSC symposium on antimicrobial drug discovery

Organised by:

SCI’s Fine Chemicals Group and RSC’s Biological and Medicinal Chemistry Sector

Online webinar

Register your Interest

At a time when antimicrobial resistance is decreasing the efficacy of existing treatments, it has never been more important that we refresh the drug pipeline with new therapeutics acting on new targets or exhibiting novel modes of action.
Fortunately, renewed interest from both industry and academia has led to a resurgence in antimicrobial drug discovery and interest in developing innovative technologies and approaches for combating infection.

Coinciding with WHO’s World Antibiotics Awareness week, this two-day meeting will examine the latest advances in antimicrobial drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing antimicrobials whilst also showcasing emerging strategies for tackling infection.


Call for Posters and Flash Presentations 
Anyone wishing to present a poster should submit a one-page abstract to conferences@soci.org by Friday 10 September 2021 with "AM-III – poster abstract" in the subject line. Selected poster presenters will have the opportunity to give a flash presentation.

Bringing together leading exponents in the field from industry and academia, the meeting will appeal to anyone with an interest in antimicrobial resistance and antimicrobial drug discovery.  And with great opportunities for academic–industrial partnerships, researchers from both sectors will also benefit from the networking opportunities that the meeting will offer.


Confirmed speakers and sessions: 

Addressing unusual anti-infective targets, Professor Anna Hirsch, Helmholtz Institute of Pharmaceutical Research, Saarland, Germany

Discovery of ETX0462, a novel non-beta-lactam PBP inhibitor to treat Gram-negative infections, including MDR Pseudomonas aeruginosa, Dr Thomas Durand-Reville, Entasis Therapeutics, MA, USA

The truth is out there: Nature as a source of new antimicrobials and alternatives, Prof Gerry Wright, McMaster University, Canada

Tethered macrocyclic peptides, a novel antibiotic class targeting Acinetobacter baumannii, Dr Patrizio MatteiMcMaster University, Canada

More speakers will be announced in due course.

Booking Process/Deadlines

Booking terms and conditions



Organising Committee
  • Dr Liam Cox, SCI / University of Birmingham
  • Dr Caroline Low, SCI / Computational Medicinal Chemistry Consultant
  • Dr Pascal Savy, SCI / Charles River Laboratories
  • Dr Francis Wilson, RSC / Summit Therapeutics

For further information and prices, please email conferences@soci.org

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org